- Home
- IRD
IRD
OPUS GENETICS INC
as 04-11-2025 4:00pm EST
Stocks
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | FARMINGTON HILLS |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 354.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.65 - $2.18 | Next Earning Date: | 05-15-2025 |
| Revenue: | $10,992,000 | Revenue Growth: | -42.30% |
| Revenue Growth (this year): | 18.8% | Revenue Growth (next year): | 108.58% |
Latest OPUS GENETICS INC News
IRD Breaking Stock News: Dive into IRD Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
7 days ago
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
Simply Wall St.
9 days ago
Party Time: Brokers Just Made Major Increases To Their Opus Genetics, Inc. (NASDAQ:IRD) Earnings Forecasts
Simply Wall St.
10 days ago
Opus Genetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
GlobeNewswire
12 days ago
Opus Genetics to Participate in Upcoming Investor Conference in April
GlobeNewswire
14 days ago
Opus Genetics Announces Financial Results for Full Year 2024
Simply Wall St.
19 days ago
Several Insiders Invested In Opus Genetics Flagging Positive News
GlobeNewswire
23 days ago
Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting of Opus Genetics
Compare IRD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRD OPUS GENETICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.